Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 19/20 | 0.53 |
| ▸ | JAK1 | P23458 | 18/20 | 0.53 |
| ▸ | JAK3 | P52333 | 9/20 | 0.53 |
| ▸ | TYK2 | P29597 | 4/20 | 0.53 |
| ▸ | RET | P07949 | 3/20 | 0.53 |
| ▸ | ROCK1 | Q13464 | 3/20 | 0.53 |
| ▸ | DAPK3 | O43293 | 2/20 | 0.53 |
| ▸ | PAK4 | O96013 | 2/20 | 0.53 |
| ▸ | ABL1 | P00519 | 2/20 | 0.53 |
| ▸ | LTK | P29376 | 2/20 | 0.53 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 0.53 |
| ▸ | CLK2 | P49760 | 2/20 | 0.53 |
| ▸ | TNK2 | Q07912 | 2/20 | 0.53 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.53 |
| ▸ | IKBKE | Q14164 | 2/20 | 0.53 |
| ▸ | NTRK3 | Q16288 | 2/20 | 0.53 |
| ▸ | NTRK2 | Q16620 | 2/20 | 0.53 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.53 |
| ▸ | TAOK1 | Q7L7X3 | 2/20 | 0.53 |
| ▸ | CAMK1D | Q8IU85 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL27231611 | 0.95 | JAK2 (0.57) | JAK2JAK1JAK3TYK2RET | |
| SCHEMBL101257 | 0.94 | JAK2 (0.55) | JAK2JAK1JAK3TYK2RET | |
| SCHEMBL101258 | 0.94 | JAK2 (0.55) | JAK2JAK1JAK3TYK2RET | |
| SCHEMBL13774673 | 0.94 | JAK2 (0.55) | JAK2JAK1JAK3TYK2RET | |
| SCHEMBL30663312 | 0.87 | JAK2 (0.57) | JAK2JAK1JAK3TYK2RET | |
| SCHEMBL101692 | 0.87 | JAK2 (0.57) | JAK2JAK1JAK3TYK2RET | |
| SCHEMBL101693 | 0.87 | JAK2 (0.57) | JAK2JAK1JAK3TYK2RET | |
| Trifluoroacetic Acid SCHEMBL99863 | 0.87 | JAK2 (0.49) | JAK2JAK1JAK3TYK2RET | |
| SCHEMBL101170 | 0.86 | JAK2 (0.56) | JAK2JAK1JAK3TYK2RET | |
| SCHEMBL99389 | 0.82 | JAK2 (0.52) | JAK2JAK1JAK3TYK2RET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117120055-A | Combination therapy comprising a JAK pathway inhibitor and a ROCK inhibitor | 因赛特公司 | 2023-11-24 | — | — | CN | claimed |
| CN-117964625-A | Preparation method of high-optical-purity ponatinib intermediate | 安徽万邦医药科技股份有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117120055-A | Combination therapy comprising a JAK pathway inhibitor and a ROCK inhibitor | 因赛特公司 | 2023-11-24 | — | — | CN | disclosed |
| CN-116879450-A | Method for separating and purifying reed-keatinib precursor by using supercritical fluid chromatography system | 江苏汉邦科技股份有限公司 | 2023-10-13 | — | — | CN | disclosed |
| CN-116761792-A | Methods and intermediates for preparing JAK inhibitors | 因赛特公司 | 2023-09-15 | — | — | CN | disclosed |